Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    iBio Inc.

    NASDAQ: IBIO · Real-Time Price · USD
    0.85
    -0.02 (-2.75%)
    At close: Jun 17, 2025, 3:44 PM

    iBio Statistics

    Share Statistics

    iBio has 16.52M shares outstanding. The number of shares has increased by 14.51% in one year.

    Shares Outstanding

    n/a
    		 16.52M

    Shares Change (YoY)

    n/a
    		 14.51%

    Shares Change (QoQ)

    n/a
    		 7.93%

    Owned by Institutions (%)

    n/a
    		 28.61%

    Shares Floating

    n/a
    		 15.84M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,492

    FTD / Avg. Volume

    n/a
    		 0.59%

    Short Selling Information

    The latest short interest is 633.8K, so 3.84% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 633.8K

    Short % of Shares Out

    n/a
    		 3.84%

    Short % of Float

    n/a
    		 3.84%

    Short Ratio (days to cover)

    n/a
    		 1.87

    Valuation Ratios

    The PE ratio is -0.31 and the forward PE ratio is -0.67. iBio's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.31

    Forward PE

    n/a
    		 -0.67

    PS Ratio

    n/a
    		 34.22

    Forward PS

    n/a
    		 182.7

    PB Ratio

    n/a
    		 0.36

    P/FCF Ratio

    n/a
    		 -0.41

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for iBio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.21.

    Current Ratio

    n/a
    		 4.08

    Quick Ratio

    n/a
    		 4.08

    Debt / Equity

    n/a
    		 0.21

    Debt / EBITDA

    n/a
    		 -0.32

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 -96.71

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $14,062.5

    Profits Per Employee

    n/a
    		 $-1,556,687.5

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -62.17% in the last 52 weeks. The beta is 0.94, so iBio's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 -62.17%

    50-Day Moving Average

    n/a
    		 0.97

    200-Day Moving Average

    n/a
    		 2.51

    Relative Strength Index (RSI)

    n/a
    		 42.72

    Average Volume (20 Days)

    n/a
    		 1,107,982

    Income Statement

    In the last 12 months, iBio had revenue of 225K and earned -24.91M in profits. Earnings per share was -6.5.

    Revenue

    n/a
    		 225K

    Gross Profit

    n/a
    		 225K

    Operating Income

    n/a
    		 -16.63M

    Net Income

    n/a
    		 -24.91M

    EBITDA

    n/a
    		 -14.02M

    EBIT

    n/a
    		 -15.27M

    Earnings Per Share (EPS)

    n/a
    		 -6.5
    Full Income Statement

    Balance Sheet

    The company has 14.21M in cash and 4.46M in debt, giving a net cash position of 9.75M.

    Cash & Cash Equivalents

    n/a
    		 14.21M

    Total Debt

    n/a
    		 4.46M

    Net Cash

    n/a
    		 9.75M

    Retained Earnings

    n/a
    		 -313.85M

    Total Assets

    n/a
    		 19.1M

    Working Capital

    n/a
    		 663K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -18.55M and capital expenditures -210K, giving a free cash flow of -18.76M.

    Operating Cash Flow

    n/a
    		 -18.55M

    Capital Expenditures

    n/a
    		 -210K

    Free Cash Flow

    n/a
    		 -18.76M

    FCF Per Share

    n/a
    		 -4.9
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -7392.89% and -11069.78%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -7392.89%

    Pretax Margin

    n/a
    		 -6863.56%

    Profit Margin

    n/a
    		 -11069.78%

    EBITDA Margin

    n/a
    		 -6231.56%

    EBIT Margin

    n/a
    		 -7392.89%

    FCF Margin

    n/a
    		 -8339.56%

    Dividends & Yields

    IBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IBIO is $5, which is 474.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 474.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 29, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -25.68

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist